BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Rethinking Clinical Trials - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Rethinking Clinical Trials
X-ORIGINAL-URL:https://rethinkingclinicaltrials.org
X-WR-CALDESC:Events for Rethinking Clinical Trials
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240320T120000
DTEND;TZID=America/New_York:20240320T130000
DTSTAMP:20260501T214552
CREATED:20240313T180739Z
LAST-MODIFIED:20240313T180739Z
UID:33526-1710936000-1710939600@rethinkingclinicaltrials.org
SUMMARY:Mind the Gap Webinar Series: Deconstruction of the Type 2 Hybrid Effectiveness-Implementation Study Design that Uses Two Randomized Controlled Trials
DESCRIPTION:Deconstruction of the Type 2 Hybrid Effectiveness-Implementation Study Design that Uses Two Randomized Controlled Trials\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nRegister now \n\n\n\n\nPresented byJune Stevens\, Ph.D. \nMarch 20\, 202412:00 noon–1:00 p.m. ET\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAbout the Webinar\nImplementation research addresses barriers to the successful conduct of interventions aimed at improving health. Thus\, implementation scientists are often interested in examining both the success of implementation strategies and health interventions. It can be argued that the most rigorous design to accomplish that goal would employ two randomized controlled trials—one testing implementation strategies on implementation outcomes and one testing an intervention on health-related outcomes. This type of study is called a dual randomized controlled trial (DRCT). Although the utility of the DRCT design is evident\, the limited literature review revealed that this design is rare in the published literature. \nThis webinar reviews the basic components of implementation-effectiveness studies. Dr. Stevens will then construct a paradigm that breaks down the components of the DRCT and provide a step-by-step explanation of features of the design and recommendations for use. The design includes a minimum of three randomized arms\, each comprised of an active or control implementation strategy paired with an active or control intervention. Examples are shown to demonstrate the use of the paradigm in different research settings. \nAbout June Stevens\nDr. June Stevens is an Epidemiologist at the University of North Carolina (UNC) at Chapel Hill with over 25 years of experience as the Principal Investigator (PI) of NIH-funded Coordinating Centers for multi-center trials that are community-based. Currently she is PI of the Research Coordinating Center for the Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) Alliance\, which includes seven centers from around the country conducting implementation studies aimed at reducing disparities in cardiovascular risk. She has generated more than $32 million dollars in national-level grant funding as PI. \nDr. Stevens served as Chair of the Department of Nutrition at UNC during the years that the graduate program was given a No. 1 ranking by the National Research Council\, along with only three other Nutrition Departments in the United States. She has chaired NIH workshops and working groups tasked with recommending clinical guidelines. She is a recipient of the Lifetime Achievement Award from the Obesity Society and the Centrum Research Award for Senior Investigators from the American Society for Nutrition\, and holds a Distinguished Professorship from the American Institute for Cancer Research. She has been an invited expert for the World Health Organization\, the American Heart Association\, the Centers for Disease Control and Prevention\, and numerous NIH study sections. \n\n\n\n\n\n\n\n\n\n\n\n\n\nCan’t be there? A recording of this webinar will be available approximately 2 weeks after the session. You can view the full archive of previous Methods: Mind the Gap webinars on the Office of Disease Prevention website. \nThis event is open to the public and there will be an opportunity to ask questions at the end of the presentation. Please feel free to share this information widely. For more information\, please contact us at MindtheGap@nih.gov.
URL:https://rethinkingclinicaltrials.org/event/mind-the-gap-webinar-series-deconstruction-of-the-type-2-hybrid-effectiveness-implementation-study-design-that-uses-two-randomized-controlled-trials/
END:VEVENT
END:VCALENDAR